Overview
Investors searching MORPHO vs INJ usually want a clear market-cap and momentum snapshot. MORPHO prints $1.93 (-1.99%) while Injective is at $4.98 (+1.20%), with volume edge currently on Injective.
Quick winners
Full comparison
| Metric | MORPHO | INJ |
|---|---|---|
| Price | $1.93 | $4.98 |
| Market Cap | $1.26B | $490.41M |
| FDV | — | — |
| Volume 24h | $842,308.47 | $2.75M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 57.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | MORPHO | INJ |
|---|---|---|
| 1H | — | — |
| 24H | -1.99% | +1.20% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | MORPHO | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.07 |
| Trend | bearish | neutral |
| Momentum | 67.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight bearish conditions on MORPHO and neutral on INJ. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | MORPHO | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
MORPHO
Injective
Pros and cons
Pros of MORPHO
- MORPHO often anchors narratives that attract sustained media and analyst coverage.
- Market-cap scale on MORPHO may dampen some idiosyncratic shocks versus smaller peers.
- MORPHO has an established coin page footprint on PEPS for continuous monitoring.
- MORPHO typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
Cons of MORPHO
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- When dominance narratives fade, MORPHO can lag hotter rotation names.
- Indicator stacks on MORPHO may stay stretched longer than expected in strong trends.
Pros of Injective
- If technical momentum aligns, Injective may outperform on medium-term windows.
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Diversifying versus MORPHO with Injective can change portfolio factor exposure.
Cons of Injective
- Incomplete fundamental coverage can hide operational or tokenomic risks.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
For readers asking which is “better”, the honest answer is conditional. MORPHO and Injective solve overlapping but not identical market jobs. On-chain and developer fields, when available, add slower-moving context beneath the tape. Missing fundamentals should be treated as unknown, not as zeros. If your thesis is long-term adoption, weight fundamentals and liquidity; if tactical, weight trend/momentum — and always define invalidation.
FAQ
Which is better, MORPHO or Injective?
“Better” depends on horizon and risk. MORPHO leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, MORPHO or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both MORPHO and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Injective currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.